PENGARUH KONSENTRASI SODIUM STARCH GLYCOLATE SEBAGAI SUPERDISINTEGRAN (0% DAN 20%) TERHADAP KARAKTERISTIK FISIK ORALLY DISINTEGRATING TABLET ATENOLOL
Abstract
Abstract - Some geriatric patients have difficulty in swallowing tablets, resulting non-compliance issues on patient. Respond from the issues, people developed an oral dosage tablet which easily become soft and rapidly disintegrate in mouth which called orally disintegrating tablet (ODT). Atenolol is one of the anti-hypertension drugs. Atenolol is classified as antagonist selective β1 receptor class that gives the effect of anti-hypertension with low bioavailability, it is necessary to change atenolol dosage forms become ODT to increased absorption of the drug in the body. To accelerate the disintegration time (less than 3 minutes) is used disintegrant sodium starch glycolate with concentration of 0% and 20%. The method that used in the tablet’s manufacture is a direct compresssion. The result of the ODT evaluation, tablet dispersion time in vitro, wetting time , water absorption ratio, and dissolution test with its parameters include (AUC, ED and kr) were analysed statistically using one way ANOVA. There a significant difference (α = 0,05) between the formulas that using sodium starch glycolate 0% and 20% in terms of tablet’s dispersion time in vitro, wetting time, water absorption ratio, dissolution test with its parameters include (AUC, ED and kr). The formula that gives the best result is the one that using 20% disintegran sodium starch glycolate because disintegration time in 19,85±0,95 seconds, tablet’s dispersion time in vitro 29,00±1,00 seconds, wetting time 23,33±1,53 seconds, water absorption ratio 555±28,45%, TQ% 1,41 minutes, the Q% 90,64±0,44%, AUC 10134,52±29,49% minutes, ED 84,45±0,27%, and kr 0,0056/minutes.
Downloads
References
Agoes G, 2012, Sediaan Farmasi Padat, 1st edition, ITB, Bandung, 357-368
Augsburger LL, Hoag SW, Pharmaceutical Dosage Forms: Tablets, 3rd edition, New York, Informa Healthcare USA, 220-239
Bhalerao AV et al, 2009, Development and Evaluation of Clonazep am Fast Disintegrating Tablets Using Superdisintegrants and Solid Dispersion Technique, Research Journal Pharmaceutical and Technology, Vol.2 (2): 375.377
Bhowmik D, Krishnakanth CB, Pankaj, dan Chandira RM, 2009, Fast Dissolving Tablet: An Overview, J. Chem and Pharm Res. 1 (1): 163-177
Camarco W, Ray D, Druffner A, 2006, Selecting Superdisintegrants for Orally Disintegrating Tablet Formulations, Pharmaceutical Technology, http://pharmtech.findpharma.com/pharmtech/articleDetail.jsp?id=378398, diakses tanggal 5 Maret 2016.
Chandrasekhar P, Mohammad SS, dan B abu MN, 2013, Formulation and Evaluation of Oral Dispersible Tablets of Anti Hypertensive Drug Atenolol, International Journal of Pharmacy. 3 (2): 79-84
Departemen Kesehatan Republik Indonesia, 2014, F armakope Indonesia, 5thedition, Departemen Kesehatan Republik Indonesia, Jakarta, 52,179
Gunawan SG, 2008, Farmakologi dan terapi, 5th edition, Departemen Farmakologi dan Fakultas Kedokteran Universitas Indonesia, Jakarta, 341-360
Hadisoewignyo L, Fudholi A, 2013, Sediaan Solida, Pustaka Pelajar, Yogyakarta, 7-10, 60-66, 89-150
Hirani JJ, Rathod DA, d an Vadalia KR, 2009, Orally Disintegrating Tablets: A Review, Tropical Journal of Pharmaceutical Research. 8 (2). 161-172
Karthikeyan M, Karthikra ja M, Rooswelt C, Lokesh D, Ve nkateswariu Y, dan Naresh Y, 2013, Formulation and Evaluation of Oral Dispersible Tablets of Atenolol by Using Superdisintegrates, International Journal of Biological. 3(1): 663-671
Komisi Farmakope Eropa, 2005, European Pharmacopoeia 5th edition, Dewan Eropa, Uppsala
Mangal M, Thakra l S, Goswami M dan Ghai P, 2012, Superdisinteg rant: An Updated Review, Aka l College of Pharmacy and Technical Education Mastuana Sahib (Pb), 26-35
Rowe, Sheskey, dan Owen (editor), 2006, Handbook of Pharmaceutical Excipients, 5th edition, American Pharmac eutical Association, Pharmaceutical Press, London.
Sulaiman TNS, 2007, Teknologi dan Formulasi Sediaan Tablet, Pustaka Laboratorium Teknologi Farmasi Fakultas Farmasi Universitas Ga djah Mada, Yogyakarta, 80-110,128,150-159,200
United States Pharmacopeial Convention, 2014, United States Pharmacopea 37 National Formulary 32, United States Phar macopeial Convention, Maryland, 40,1858.
Wardhana, Yogawindhu., 2007, F ormulasi Tablet Kun yah Serbuk J ahe Kuning (Zingiber Gramineum Bi), Fakultas Farmasi Universitas Padjadjaran, Sumedang
- Articles published in CALYPTRA are licensed under a Creative Commons Attribution-ShareAlike 4.0 International license. You are free to copy, transform, or redistribute articles for any lawful purpose in any medium, provided you give appropriate credit to the original author(s) and the journal, link to the license, indicate if changes were made, and redistribute any derivative work under the same license.
- Copyright on articles is retained by the respective author(s), without restrictions. A non-exclusive license is granted to CALYPTRA to publish the article and identify itself as its original publisher, along with the commercial right to include the article in a hardcopy issue for sale to libraries and individuals.
- By publishing in CALYPTRA, authors grant any third party the right to use their article to the extent provided by the Creative Commons Attribution-ShareAlike 4.0 International license.